Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Cell
|
May 2, 2006
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling
Zachary A Knight, Beatriz Gonzalez, Morri E Feldman, et al.
Molecular Cancer Research : MCR
|
April 18, 2009
Genetic alterations and oncogenic pathways associated with breast cancer subtypes
Xiaolan Hu, Howard M Stern, Lin Ge, et al.
Cancer Research
|
April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes
Genee Y Lee, Peter M Haverty, Li Li, et al.
Nature Medicine
|
December 13, 2006
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T Parsa, James S Waldron, Amith Panner, et al.
Molecular Cancer Research : MCR
|
August 13, 2009
Oncogenic activating mutations are associated with local copy gain
Barmak Modrek, Lin Ge, Ajay Pandita, et al.
Journal of Neuro-Oncology
|
August 26, 2009
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
Sean M McBride, Daniel A Perez, Mei-Yin Polley, et al.
Blood
|
December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Mignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Cancer Research
|
August 17, 2019
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
Steffan Vartanian, James Lee, Christiaan Klijn, et al.
Nature
|
February 5, 2010
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou, Kyung Song, Ivana Yen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2012
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
Till Maurer, Lindsay S Garrenton, Angela Oh, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Cell
|
May 2, 2006
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling
Zachary A Knight, Beatriz Gonzalez, Morri E Feldman, et al.
Molecular Cancer Research : MCR
|
April 18, 2009
Genetic alterations and oncogenic pathways associated with breast cancer subtypes
Xiaolan Hu, Howard M Stern, Lin Ge, et al.
Cancer Research
|
April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes
Genee Y Lee, Peter M Haverty, Li Li, et al.
Nature Medicine
|
December 13, 2006
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T Parsa, James S Waldron, Amith Panner, et al.
Molecular Cancer Research : MCR
|
August 13, 2009
Oncogenic activating mutations are associated with local copy gain
Barmak Modrek, Lin Ge, Ajay Pandita, et al.
Journal of Neuro-Oncology
|
August 26, 2009
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
Sean M McBride, Daniel A Perez, Mei-Yin Polley, et al.
Blood
|
December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Mignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Cancer Research
|
August 17, 2019
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
Steffan Vartanian, James Lee, Christiaan Klijn, et al.
Nature
|
February 5, 2010
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou, Kyung Song, Ivana Yen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2012
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
Till Maurer, Lindsay S Garrenton, Angela Oh, et al.
Page
of 9